SUPRIYA.BOBSE
Supriya Lifescience Limited
₹977.00
ListedDec 28, 2021
SectorHealthcare
IndustryBiotechnology
CountryIndia
Employees-
State-| CityMumbai| Address207/208 Udyog Bhavan| Phone91 22 4033 2727
Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. The company offers active pharmaceuticals ingredients in antihistamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, anti–hypertensive, vitamins, anti-malarial, and anti-gout areas. It also provides oncology, veterinary, and general category products. In addition, the company offers GelHeal, a wound care solution; and Quickblue, an oral cancer detection kit. Further, it is developing drugs in the areas of anti-depressant, anti-inflammatory, contrast media, hormones, antibiotic, smoking cessation, anti-diabetic/obesity, anti-ataxia, decongestant, veterinary API, anti-cancer, allogeneic hematopoietic stem cell transplantation, and anti-migraine. Supriya Lifescience Limited was founded in 1987 and is headquartered in Mumbai, India.

Key Indicators

Key financial and dividend metrics for this stock.

?
P/E Ratio
37.6
?
Div. Rate
₹1.00
?
Div. Yield
0.10%
?
Payout Ratio
3.85%
?
Max Consec. Div. Years
4 years
?
Longest Consec. Div.
4 years
?
Div. Coverage
100%
?
Div. Stability Rate
0.26
?
Div. Growth Rate
67.00%
?
Score
86

Dividend History

Historical dividend payments by ex-dividend date.

Sep 4, 2025
₹ 1.0000
Sep 20, 2024
₹ 0.8000
Sep 15, 2023
₹ 0.6000
Sep 1, 2022
₹ 0.6000

Peer Companies

Other stocks in the same sector.

The app download will be available in the next version. Stay tuned!